Does the serum IL-17 titer influence the efficacy of interferon-β treatment in multiple sclerosis patients?
Authors:
Rodica Bălaşa, Adina Huţanu, Z. Bajko, Camelia Feier, I. Pascu
2
Incidence and clinical significance of binding antibodies and their relationships with neutralizing antibodies, both induced by interferon-β treatment in multiple sclerosis patients